A sequential regimen of romosozumab followed by alendronate is more effective than alendronate alone for increasing bone mass in women with osteoporosis, results from the ARCH trial show.
Medscape Medical News …read more
A sequential regimen of romosozumab followed by alendronate is more effective than alendronate alone for increasing bone mass in women with osteoporosis, results from the ARCH trial show.
Medscape Medical News …read more